User:Blent/Seminar 07 fall: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 2: Line 2:
* Toward Personalized Medicine in BMI-based Methodology: A case study of [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] and challenges in the future
* Toward Personalized Medicine in BMI-based Methodology: A case study of [http://en.wikipedia.org/wiki/Carbamazepine Carbamazepine] and challenges in the future
==Outlines (Sep 27, 2007)==
==Outlines (Sep 27, 2007)==
* What is personalized medicine
* What is personalized medicine
** personalized biomedical data collection and analysis
** personalized biomedical data collection and analysis
Line 9: Line 8:
*** which medicine should one take? (decision of medicine)
*** which medicine should one take? (decision of medicine)
*** how much medicine should one take? (dosage of medicine)
*** how much medicine should one take? (dosage of medicine)
* case study: CBZ-SJS  
* case study: CBZ-SJS  
** [http://www.nature.com/nature/journal/v428/n6982/full/428486a.html Medical genetics: a marker for Stevens-Johnson syndrome, Nature 2004 April]
** [http://www.nature.com/nature/journal/v428/n6982/full/428486a.html Medical genetics: a marker for Stevens-Johnson syndrome, Nature 2004 April]
Line 18: Line 15:
** [http://www.libertytimes.com.tw/2007/new/sep/18/today-life7.htm 預防抗癲癇藥害 明年起先測基因 - 首見研究成果當警語 (自由時報生活新聞 9/18, 2007)]
** [http://www.libertytimes.com.tw/2007/new/sep/18/today-life7.htm 預防抗癲癇藥害 明年起先測基因 - 首見研究成果當警語 (自由時報生活新聞 9/18, 2007)]
** [http://www.epochtimes.com/b5/7/9/18/n1837459.htm 台灣獨步全球 預防抗癲癇藥害 - 明年起先測基因 首見研究成果當警語 (大紀元電子報 9/18, 2007)]
** [http://www.epochtimes.com/b5/7/9/18/n1837459.htm 台灣獨步全球 預防抗癲癇藥害 - 明年起先測基因 首見研究成果當警語 (大紀元電子報 9/18, 2007)]
* case study: 抗凝血劑之使用劑量評估
* case study: 抗凝血劑之使用劑量評估
* case study: Diabetes and Diagnosis
* case study: Diabetes and Diagnosis
* BioBank and Biomarkers discovery
* BioBank and Biomarkers discovery
* case study: The First race-specific drug '''Bibil'''
* case study: The First race-specific drug '''Bibil'''
** [http://www.liverx.org/2007/09/05/藥瓶裡的種族問題/ 活力藥師網番外篇-藥瓶裡的種族問題]
** [http://www.liverx.org/2007/09/05/藥瓶裡的種族問題/ 活力藥師網番外篇-藥瓶裡的種族問題]
Line 30: Line 23:
** 藥瓶裡的種族問題 科學人 2007 Sep
** 藥瓶裡的種族問題 科學人 2007 Sep
** author: [http://www.hamline.edu/law/facadmin/jonathon_kahn.html Jonathan Kahn]
** author: [http://www.hamline.edu/law/facadmin/jonathon_kahn.html Jonathan Kahn]
* ELSI, Biobank and FDA guide lines
* ELSI, Biobank and FDA guide lines
* Movies
* Movies

Revision as of 21:29, 28 September 2007

Title

  • Toward Personalized Medicine in BMI-based Methodology: A case study of Carbamazepine and challenges in the future

Outlines (Sep 27, 2007)

Outlines (Sep 20, 2007)

  • BMI = BI + MI
    • what BMI can do
      • Neuroinformatics (NI)
      • Cancer research (CR)
  • Personalized Medicine (PM)

Background

Materials

Notes